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In this issue, Stetson et al. (2008) report a mechanism by which host cells avert an autoimmune 
response to self-nucleic acids. They show that the nuclease Trex1 prevents the accumulation of 
DNA derived from endogenous retroelements that, if left unchecked, trigger elevated production 
of type I interferons leading to autoimmunity.Cell 134, August 22, 2008 ©2008 Elsevier Inc. 569The detection of viral nucleic acids by 
pathogen recognition receptors leads to 
the production of type I interferons (IFNs) 
through the activation of NF-κB and 
interferon regulatory factors (IRFs) (Akira 
et al., 2006). Although they are a critical 
element in the response of mammalian 
cells to viral infection, uncontrolled pro-
duction of IFNs can also have pathologi-
cal consequences, including the devel-
opment of autoimmune disease. In this 
issue, Stetson et al. (2008) report a new 
mechanism that suppresses the del-
eterious induction of IFNs in mice. They 
show that the nuclease Trex1 prevents 
the accumulation of reverse-transcribed 
DNA derived from endogenous retroele-
ments that can trigger IFN production. 
These findings reveal an unexpected link 
between retroelements and the develop-
ment of autoimmune disease.
Trex1 is an abundant 3′ > 5′ exonu-
clease known to digest single-stranded 
DNA (ssDNA) (Mazur and Perrino, 1999), 
and loss-of-function mutations of Trex1 
in humans cause autoimmune diseases 
including Aicardi-Goutieres Syndrome 
(AGS) and familial chilblain lupus (Crow 
et al., 2006a). Recent studies have also 
identified mutations in Trex1 that are 
associated with systemic lupus ery-
thematosus (Lee-Kirsch et al., 2007). 
Although mice lacking Trex1 do not 
develop Aicardi-Goutieres Syndrome or 
lupus, they have increased mortality due 
to inflammatory myocarditis (Morita et 
al., 2004).
To investigate the mechanism under-
lying the autoimmune diseases caused 
by Trex1 deficiency, Stetson et al. bred 
the Trex1-deficient mice with mice lack-
ing IRF3, the IFN receptor (IFNαR1), or RAG2, a DNA recombinase required for 
the generation of functional lympho-
cytes. Strikingly, in each case, the mor-
tality and cardiac inflammation observed 
in Trex1-deficient mice were nearly com-
pletely rescued. In addition, the induction 
of IFN-β by the loss of Trex1 was abro-
gated by compound deletion of IRF3 or 
IFNαR1. These results provide compel-
ling evidence that the activation of the 
IRF3 pathway is responsible for the auto-
immune diseases caused by Trex1 defi-
ciency, at least in mice. However, IFN-β 
induction was observed in mice lacking 
both Trex1 and RAG2, suggesting that 
the induction of IFNs is not sufficient to 
cause the autoimmune phenotypes in 
the absence of lymphocytes.
How might the loss of Trex1 cause IRF3 
activation? Given that Trex1 is a DNA 
nuclease, a reasonable hypothesis is that 
cells lacking Trex1 accumulate DNA that 
activates the IRF3 pathway. Sequence 
analysis of cytosolic DNA purified from 
hearts of mice lacking Trex1 showed that 
they had markedly more cytosolic DNA 
than wild-type hearts. Moreover, Stetson 
et al. observed a striking increase in 
the proportion of DNA corresponding 
to endogenous retroelements. Further, 
overexpression of Trex1 inhibited the 
retrotranscription and integration of 
two synthetic retroelements (LTR-type 
and L1). In contrast, Trex1 harboring 
catalytic site mutations associated with 
autosomal dominant Aicardi-Goutieres 
Syndrome were unable to prevent ret-
rotransposition of an LTR-containing 
element although there was no effect on 
L1 retrotransposition. These results sug-
gest that a class of Trex1 substrates is 
derived from retroelements.The proposal that Trex1 metabo-
lizes DNA derived from retroelements 
fits nicely with human genetic stud-
ies that identify several mutations in 
genes encoding subunits of RNase H2 
in patients with Aicardi-Goutieres Syn-
drome (Crow et al., 2006b). Like carri-
ers of Trex1 mutations, patients carrying 
RNase H2 mutations also have elevated 
levels of IFN-α and develop circulating 
antinuclear antibodies. That mutations in 
Trex1 and RNase H2 lead to very similar 
autoimmune diseases strongly suggests 
that they function in the same pathway. 
In light of the new data, it is likely that 
RNase H2 and Trex1 share a common 
substrate, the DNA:RNA hybrid derived 
from endogenous retroelements (Figure 
1).
However, retroelement-derived DNA 
may not be the only substrate metabo-
lized by Trex1. A previous study found 
that Trex1-deficient mouse embry-
onic fibroblasts (MEFs) had cell-cycle 
defects resulting from chronic acti-
vation of a DNA-damage checkpoint 
(Yang et al., 2007). Interestingly, single-
stranded DNA (ssDNA) accumulates 
in the endoplasmic reticulum (ER) in 
MEFs lacking Trex1 but not in wild-type 
MEFs. This may be significant as Trex1 
is localized to the ER membrane and 
a missense mutation that generates a 
truncated protein lacking the C-terminal 
ER localization domain has been linked 
to autosomal dominant retinal vascu-
lopathy with cerebral leukodystrophy 
(Chowdhury et al., 2006; Richards et 
al., 2007). Isolation of cytoplasmic DNA 
from Trex1-deficient MEFs revealed a 
discrete band corresponding to ssDNA 
of 60–65 nucleotides that is absent in 
wild-type MEFs. Based on these obser-
vations, Yang et al. proposed that Trex1 
is involved in the metabolism of ssDNA 
generated as a result of aberrant DNA 
replication (Yang et al., 2007). Surpris-
ingly, Stetson et al. found no apparent 
cell-cycle defect or activation of the 
DNA-damage checkpoint in primary 
Trex1-deficient MEFs. These differing 
results warrant further study of the role 
of Trex1 in the surveillance of DNA rep-
lication and damage products. Given 
that the disease in Trex1-deficient 
mice can be “cured” by deleting IRF3, 
IFNαR1, or RAG2, aberrant activation 
of the IRF3 pathway would appear to 
be the major contributor to the pheno-
type. However, retroelement-derived 
DNA may not be the sole activator of 
the IRF3 pathway in the case of Trex1 
deficiency. It is possible that the dis-
tinct ER-associated ssDNA identified 
by Yang et al., which may or may not be 
encoded by retroelements, could con-
tribute to IRF3 activation. It is also pos-
sible that ssDNA-induced DNA damage 
leads to IRF3 activation. IRF3 and IFNs 
are also known to activate p53, which 
may cause cell-cycle arrest, senes-
cence, or apoptosis. Further complicat-
ing the issue, Trex1 has been shown to 
be a part of a nuclease complex known 
as SET that is localized to the ER. SET 
degrades ssDNA to facilitate caspase-
independent cell death by granzyme A 
and perforin (Chowdhury et al., 2006). 
Thus, multiple substrates of Trex1 may 
accumulate in the absence of Trex1 and 
activate the IRF3 pathway.
The work of Stetson et al. raises sev-
eral important questions. What are the 
ligands that activate the IRF3 pathway? 
In principle, these ligands could include 
DNA:RNA hybrids, single-stranded 
DNA, or double-stranded DNA (Fig-
ure 1). What and where is the sensor 
(or sensors) that detects the retroele-
ment-derived ligand(s)? Where does 
the catabolism of retroelement-derived 
DNA take place in the cell and how does 
reverse-transcribed DNA gain access 
to Trex1 or a putative DNA sensor? Do 
retroviral infections induce IFN produc-
tion through the same mechanism as 
the endogenous retroelements? Finally, 
can blocking reverse transcription of 
retroelements prevent autoimmunity 
caused by the loss of Trex1 or RNase 
H2? Stetson et al. began to address this 
question and found that AZT, a reverse 
transcriptase inhibitor, did not allevi-
ate the disease phenotypes in Trex1-
deficient mice; however, as they pointed 
out, AZT may not inhibit all reverse tran-
scriptases in cells. Further investigation 
into these questions should yield deep 
insights into this cell-intrinsic mecha-
nism of autoimmunity.
Figure 1. Nucleic Acid Sensing and Autoimmunity
(A) Single-stranded DNA (ssDNA) and DNA:RNA hybrids generated during the replication of retroviruses 
or endogenous retrotransposons may normally be degraded by the RNase H2 and Trex1 nucleases. 
Mutations inactivating either enzyme result in the accumulation of these nucleic acids, which through 
putative sensors lead to inappropriate activation of IRF3. Activated IRF3 induces the synthesis of type I 
interferons (IFNs), which stimulate the immune system leading to autoimmune diseases including Aicardi-
Goutieres Syndrome (AGS) and systemic lupus erythematosus (SLE). 
(B) Toll-like receptors (TLRs) 3, 7/8, and 9 detect double-stranded RNA (dsRNA), single-stranded RNA 
(ssRNA), and CpG DNA, respectively, which are derived from pathogens or phagocytosed apoptotic cells. 
Upon binding to these ligands within endosomes, TLRs activate a signaling cascade leading to the acti-
vation of IRF3. Activated IRF3 enters the nucleus and together with other activated transcription factors 
induces IFN production. In the cytosol, virally derived RNAs bind to the RNA helicases, RIG-I and MDA5, 
which then activate IRF3, resulting in IFN production. A feedforward loop that stimulates this RNA-sensing 
pathway is induced by IFNs. 2′-5′ oligoadenylate synthetase (2′-5′OAS), an IFN-induced protein, synthe-
sizes 2′-5′ linked oligoadenylate (OA) from ATP. OA binds to and stimulates another IFN-induced protein, 
RNaseL, which processes cytosolic host RNA into small RNA to activate RIG-I and MDA5. Cytosolic dsDNA 
derived from bacteria, viruses, or the host also activate IRF3 through an unidentified receptor. Recent data 
implicating the DNA exonuclease, Trex1, in the regulation of IRF3 suggest the existence of a receptor sys-
tem that detects DNA-containing species generated during the replication of endogenous retrotransposons 
and retroviruses. In cells lacking functional Trex1, these DNA species accumulate and activate IRF3 and 
IFN synthesis. Appropriate stimulation by IFNs during infections leads to antiviral immune responses while 
inappropriate activation, sometimes in the absence of infection, can lead to autoimmunity. PRR: pattern 
recognition receptor; 5′pppRNA: 5′-triphosphorylated RNA. RT: reverse transcriptase.570 Cell 134, August 22, 2008 ©2008 Elsevier Inc.
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